Inventor · disambiguated record
Gunnar M. Olsen
Also filed as: OLSEN GUNNAR · OLSEN GUNNAR M
72 granted patents·37 pending applications·302 citations·filing 1996–2012
98Inventor score
Top patents by PatentIndex Score
109 records- 0193US7674899B2Dimeric azacyclic compounds and their useNEUROSEARCH AS·Filed 2005·Granted Mar 9, 2010·12 cites·5 claims
- 0292US8017631B2Oxadiazole derivatives and their medical useNEUROSEARCH AS·Filed 2006·Granted Sep 13, 2011·30 cites·2 claims
- 0392US7750011B2Diazabicyclic aryl derivatives and their medical useNEUROSEARCH AS·Filed 2006·Granted Jul 6, 2010·23 cites·16 claims
- 0489US6943159B1Compounds and their use as positive AMPA receptor modulatorsNEUROSEARCH AS·Filed 2000·Granted Sep 13, 2005·26 cites·20 claims
- 0588US7910578B28,10-diaza-bicyclo[4.3.1]decane derivatives and their medical useNEUROSEARCH AS·Filed 2007·Granted Mar 22, 2011·14 cites·10 claims
- 0686US7696350B2Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2005·Granted Apr 13, 2010·8 cites·3 claims
- 0786US6964972B28-Azabicyclo(3,2,1)oct-2 ene and octane derivatives as cholinergic ligands at nicotinic ACh receptorsNEUROSEARCH AS·Filed 2003·Granted Nov 15, 2005·20 cites·4 claims
- 0885US7652010B2Azabicyclic aryl derivatives and their medical useNEUROSEARCH AS·Filed 2005·Granted Jan 26, 2010·8 cites·17 claims
- 0985US7220741B21,4-diazabicycloalkane derivatives, their preparation and useNEUROSEARCH AS·Filed 2003·Granted May 22, 2007·22 cites·8 claims
- 1084US7514450B2Azabicyclic aryl derivativesNEUROSEARCH AS·Filed 2005·Granted Apr 7, 2009·7 cites·4 claims
- 1184US6552012B2Heteroaryl diazabicycloalkanes, their preparation and useNEUROSEARCH AS·Filed 2001·Granted Apr 22, 2003·22 cites·9 claims
- 1283US7662808B2Diazabicyclic aryl derivatives as cholinergic receptor modulatorsNEUROSEARCH AS·Filed 2005·Granted Feb 16, 2010·5 cites·4 claims
- 1382US6897219B2Heteroaryl diazacycloalkanes, their preparation and useNEUROSEARCH AS·Filed 2003·Granted May 24, 2005·16 cites·6 claims
- 1480US6825189B1Certain heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptorsNEUROSEARCH AS·Filed 2000·Granted Nov 30, 2004·13 cites·14 claims
- 1578US7547788B2Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2005·Granted Jun 16, 2009·2 cites·6 claims
- 1677US7687523B23-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonistsNEUROSEARCH AS·Filed 2007·Granted Mar 30, 2010·3 cites·7 claims
- 1777US6680328B28-azabicyclo[3.2.1]oct-2-ene and -octane derivativesNEUROSEARCH AS·Filed 2001·Granted Jan 20, 2004·8 cites·7 claims
- 1875US7807667B21,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical useNEUROSEARCH AS·Filed 2007·Granted Oct 5, 2010·1 cites·3 claims
- 1975US7781456B2Enantiomers of 3-heteroaryl-8H-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2005·Granted Aug 24, 2010·4 cites·11 claims
- 2074US7888358B28-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2008·Granted Feb 15, 2011·1 cites·2 claims
- 2173US7915272B21,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical useNEUROSEARCH AS·Filed 2007·Granted Mar 29, 2011·1 cites·3 claims
- 2271US8101598B21,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical usePETERS DAN·Filed 2010·Granted Jan 24, 2012·1 cites·11 claims
- 2371US7662812B2Diazabicyclic aryl derivatives and their use as chinolinergic ligands at nicotinic acetylcholine receptorsNEUROSEARCH AS·Filed 2006·Granted Feb 16, 2010·1 cites·14 claims
- 2471US6815438B2Heteroaryl-diazabicycloalkanesNEUROSEARCH AS·Filed 2000·Granted Nov 9, 2004·6 cites·6 claims
- 2570US7223753B2Diazabicyclic biaryl derivativesNEUROSEARCH AS·Filed 2003·Granted May 29, 2007·4 cites·4 claims
- 2668US8110588B21,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptorsNARDI ANTONIO·Filed 2008·Granted Feb 7, 2012·1 cites·9 claims
- 2768US7307087B2Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substanceNEUROSEARCH AS·Filed 2001·Granted Dec 11, 2007·2 cites·7 claims
- 2868US7202237B2Pyridylether derivatives, their preparation and useNEUROSEARCH AS·Filed 2004·Granted Apr 10, 2007·2 cites·3 claims
- 2967US7750022B2Quinuclidine derivatives and their pharmaceutical useNEUROSEARCH AS·Filed 2004·Granted Jul 6, 2010·3 cites·7 claims
- 3067US7407970B28-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2004·Granted Aug 5, 2008·2 cites·5 claims
- 3166US8236793B2Diazabicyclic aryl derivatives as cholinergic receptor modulatorsPETERS DAN·Filed 2009·Granted Aug 7, 2012·0 cites·9 claims
- 3266US7915419B2Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2009·Granted Mar 29, 2011·0 cites·4 claims
- 3366US7314870B2Compounds, their preparation and useNEUROSEARCH AS·Filed 2002·Granted Jan 1, 2008·3 cites·10 claims
- 3464US6756386B1Azaring-ether derivatives and their use as nicotinic ACh receptor modulatorsNEUROSEARCH AS·Filed 2000·Granted Jun 29, 2004·1 cites·7 claims
- 3563US7358243B2Diazabicyclonane and-decane derivatives and their use as opioid receptor ligandsNEUROSEARCH AS·Filed 2003·Granted Apr 15, 2008·3 cites·10 claims
- 3663US7064118B2Heteroaryl diazacycloalkanes, their preparation and useNEUROSEARCH AS·Filed 2001·Granted Jun 20, 2006·1 cites·7 claims
- 3762US7250425B28-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2004·Granted Jul 31, 2007·1 cites·10 claims
- 3862US7247643B28-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2004·Granted Jul 24, 2007·1 cites·9 claims
- 3962US6884807B23-substituted quinuclidines and their use as nicotinic agonistsNEUROSEARCH AS·Filed 2001·Granted Apr 26, 2005·1 cites·4 claims
- 4061US7060699B2Aryl and heteroaryl diazabicycloalkanes, their preparation and useNEUROSEARCH AS·Filed 2001·Granted Jun 13, 2006·1 cites·10 claims
- 4161US2010056567A1Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitorsPETERS DAN·Filed 2009·Application pending·0 cites
- 4260US8158619B21,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical usePETERS DAN·Filed 2007·Granted Apr 17, 2012·0 cites·8 claims
- 4359US8148365B21,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical usePETERS DAN·Filed 2007·Granted Apr 3, 2012·0 cites·3 claims
- 4459US7235548B2Compounds and their use as positive AMPA receptor modulatorsNEUROSEARCH AS·Filed 2003·Granted Jun 26, 2007·2 cites·11 claims
- 4559US2007265241A1Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substanceOLSEN GUNNAR M·Filed 2007·Application pending·0 cites
- 4658US8372832B21,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical useNEUROSEARCH AS·Filed 2012·Granted Feb 12, 2013·0 cites·5 claims
- 4758US7282494B2Heteroaryl diazacycloalkanes, their preparation and useNEUROSEARCH AS·Filed 2005·Granted Oct 16, 2007·0 cites·3 claims
- 4858US2007161614A1Pyridylether derivatives, their preparation and usePETERS DAN·Filed 2007·Application pending·0 cites
- 4957US8263617B2Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsPETERS DAN·Filed 2007·Granted Sep 11, 2012·0 cites·4 claims
- 5057US2010234349A1Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancerOLSEN GUNNAR M·Filed 2007·Application pending·0 cites
Showing the top 50 of 109 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gunnar M. Olsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →